GastroEsophageal Cancer Clinical Trials

96 clinical trials for GastroEsophageal Cancer across international registries, including 19 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Cognitive Impact Associated With Surgery For Gastric Or Esophageal Cancer — RECRUITING
• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of the Safety and Tolerability of CTX-10726 — RECRUITING · PHASE1
• PULSO Trial: Pulsed Low-Dose-Rate (PLDR) Radiation Chemoradiation (CRT) vs. Standard CRT for Esophageal Cancer — RECRUITING · PHASE2
• A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors — RECRUITING · PHASE2
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
• BEFAST Study, [68Ga]Ga-FAPI Total Body PET/CT for Better and Faster Imaging in Cancer — RECRUITING · PHASE2
• A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma — RECRUITING · PHASE1
• The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES) — RECRUITING · NA
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Support Through Remote Observation and Nutrition Guidance Program for Individuals With Gastroesophageal Cancer — RECRUITING · NA
• Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers — RECRUITING
• Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer — RECRUITING · PHASE2
• Sample Collection for Ongoing Research and Product Evaluation Study — RECRUITING
• Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer — RECRUITING · PHASE2
• A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers — RECRUITING · PHASE2
• Selective serotonin reuptake inhibition in patients with advanced gastroesophageal cancer receiving immunochemotherapy: a prospective phase II trial — RECRUITING · PHASE2
• GastrOesophageal Tumor, Immune Microenvionnment (GOTIM) — RECRUITING
• Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer — RECRUITING · NA
• A RANDOMIZED, PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF ONARTUZUMAB (MetMAb) IN COMBINATION WITH 5 FLUOROURACIL, FOLINIC ACID, AND OXALIPLATIN (mFOLFOX6) IN PATIENTS WITH METASTATIC HER2 NEGATIVE, MET-POSITIVE GASTROESOPHAGEAL CANCER — TERMINATED · PHASE3
• Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients — COMPLETED · NA
• Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers — ACTIVE_NOT_RECRUITING
• Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma — COMPLETED · PHASE2
• A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Neratinib In Combination With Chemotherapy/Trastuzumab/Pembrolizumab In HER2 Gastroesophageal Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers — COMPLETED · PHASE2
• PRO1107 in Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers — COMPLETED · PHASE1
• REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Supportive Oncology Care At Home RCT — ACTIVE_NOT_RECRUITING · NA
• A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, and Esophageal Adenocarcinoma): Substudy 06C — TERMINATED · PHASE2
• A Phase 1/2 Open-Label, Umbrella Platform Design Study to Evaluate the Safety and Efficacy of Investigational Agents in Combination With Standard of Care Treatments as the Second-Line Treatment of Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma: Substudy 06D — TERMINATED · PHASE2
• Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers — COMPLETED · PHASE1
• Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Perioperative Zanidatamab and Chemotherapy for HER2 Positive Gastroesophageal Cancer — NOT_YET_RECRUITING · PHASE1
• A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015) — ACTIVE_NOT_RECRUITING · PHASE3
• A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer — COMPLETED
• Biobanking Upper Gastrointestinal Tumors to Evaluate Response (BURGER With BACON) — WITHDRAWN
• Impact of Pretreatment Emotional Distress on Survival and the Predictive Role of Peripheral Biomarkers in Immunotherapy Response Among Gastroesophageal and Lung Cancer Patients — COMPLETED
• Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy — ACTIVE_NOT_RECRUITING
• PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy — COMPLETED · PHASE3
• Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer — TERMINATED · PHASE2
• A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy — COMPLETED · PHASE3
• A Phase II Study Evaluating an Organ Preservation Strategy Using Immune Checkpoint Blockade for Participants With Primary Colorectal or Gastroesophageal Cancer — WITHDRAWN · PHASE2
• ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer. — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors — COMPLETED · PHASE1
• A Study of DKN-01 in Combination With Paclitaxel or Pembrolizumab — COMPLETED · PHASE1
• Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors — TERMINATED

Refine this search